{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:23:43Z","timestamp":1790256223196,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.cellsig.2017.07.018","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T20:19:30Z","timestamp":1501013970000},"page":"55-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Therapeutic potentials of natural compounds acting on cyclic nucleotide phosphodiesterase families"],"prefix":"10.1016","volume":"39","author":[{"given":"Abdurazzag","family":"Abusnina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0850-1331","authenticated-orcid":false,"given":"Claire","family":"Lugnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2017.07.018_bb0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments","volume":"165","author":"Keravis","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0010","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1021\/ja01570a087","article-title":"The properties of an adenine ribonucleotide produced with cellular particles, ATP, Mg++, and epinephrine or glucagon","volume":"79","author":"Sutherland","year":"1957","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0015","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0021-9258(19)77423-7","article-title":"Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles","volume":"232","author":"Sutherland","year":"1958","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0006-291X(63)90566-7","article-title":"Isolation of adenosine 3\u2032, 5\u2032-monophosphate and guanosine 3\u2032, 5\u2032-monophosphate from rat urine","volume":"11","author":"Ashman","year":"1963","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0025","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0021-9258(18)60316-3","article-title":"Adenosine 3\u2032,5\u2032-phosphate in biological materials. I. Purification and properties of cyclic 3\u2032,5\u2032-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3\u2032,5\u2032 -phosphate in human urine","volume":"237","author":"Butcher","year":"1962","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0006-291X(70)91046-6","article-title":"Cyclic phosphodiesterase activity and the action of papaverine","volume":"40","author":"Triner","year":"1970","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00999402","article-title":"Inhibition of cyclic-3\u2032,5\u2032-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs","volume":"267","author":"Kukovetz","year":"1970","journal-title":"Naunyn Schmiedebergs Arch. Pharmakol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0026-895X(25)09714-7","article-title":"Multiple cyclic nucleotide phosphodiesterases","volume":"46","author":"Beavo","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0045","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/0006-2952(86)90333-3","article-title":"Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta","volume":"35","author":"Lugnier","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/jmbi.2001.4813","article-title":"Molecular organization of bovine rod cGMP-phosphodiesterase 6","volume":"310","author":"Kameni-Tcheudji","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0055","first-page":"63","article-title":"Assessment of phosphodiesterase isozyme contribution in cell and tissue extracts","volume":"307","author":"Keravis","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0060","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1093\/jn\/128.12.2324","article-title":"Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta","volume":"128","author":"Andriambeloson","year":"1998","journal-title":"J. Nutr."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1476-5381.1991.tb12457.x","article-title":"Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors","volume":"104","author":"Komas","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0070","article-title":"Bordeaux red wine polyphenols inhibit cyclic nucleotide phosphodiesterases isoforms","volume":"A211","author":"Lugnier","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0075","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1021\/np50060a034","article-title":"Norditerpene dilactones from Decussocarpus rospigliosii","volume":"51","author":"Amaro-Luis","year":"1988","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0080","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1055\/s-2007-990218","article-title":"Biflavones of Decussocarpus rospigliosii as phosphodiesterases inhibitors","volume":"73","author":"Chaabi","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0085","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cbic.200300787","article-title":"A powerful antiradiation compound revealed by a new high-throughput screening method","volume":"5","author":"Meunier","year":"2004","journal-title":"Chembiochem"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/jo702106u","article-title":"Total synthesis of norbadione A","volume":"73","author":"Bourdreux","year":"2008","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0095","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.bbrc.2004.07.186","article-title":"Celastrol inhibits pro-inflammatory cytokine secretion in Crohn's disease biopsies","volume":"322","author":"Pinna","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(98)00898-X","article-title":"Ginsenoside Rg3 mediates endothelium-dependent relaxation in response to ginsenosides in rat aorta: role of K+ channels","volume":"367","author":"Kim","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(98)00899-1","article-title":"The ginsenoside Rg3 evokes endothelium-independent relaxation in rat aortic rings: role of K+ channels","volume":"367","author":"Kim","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0110","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isoforms as possible intracellular targets for ginseng and ginsenosides","volume":"15","author":"Lugnier","year":"2001","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0115","series-title":"Advances in Ginseng Research","first-page":"216","article-title":"Cyclic nucleotide phosphodiesterases as possible targets for ginsenosides","author":"Lugnier","year":"1998"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jcmm.12739","article-title":"Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress-induced apoptosis in a streptozotocin-induced diabetes rat model","volume":"20","author":"Yu","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0014-2999(72)90090-8","article-title":"Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle relaxation","volume":"19","author":"Lugnier","year":"1972","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0130","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/BF01915343","article-title":"Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase","volume":"34","author":"Beretz","year":"1978","journal-title":"Experientia"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0031-6997(24)01472-8","article-title":"The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer","volume":"52","author":"Middleton","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0140","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/np9904509","article-title":"Flavonoids as antioxidants","volume":"63","author":"Pietta","year":"2000","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0163-7258(02)00298-X","article-title":"The biochemistry and medical significance of the flavonoids","volume":"96","author":"Havsteen","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00210-004-0994-6","article-title":"Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin","volume":"370","author":"Orallo","year":"2004","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-2005-837774","article-title":"Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (+\/\u2212)-naringenin","volume":"71","author":"Orallo","year":"2005","journal-title":"Planta Med."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/pb.21.4.235","article-title":"Dioclein - a new drug from an old plant","volume":"21","author":"Dunn","year":"1997","journal-title":"Lett. Brazil. Psych. Bull."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2009.08.008","article-title":"The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue","volume":"620","author":"Gon\u00e7alves","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0170","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/S0002-9149(99)00042-9","article-title":"Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro","volume":"83","author":"Wallis","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(99)00747-5","article-title":"Dioclein, a new nitric oxide- and endothelium-dependent vasodilator flavonoid","volume":"386","author":"Lemos","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.bjp.0706507","article-title":"Study of the mechanisms involved in the vasorelaxation induced by (\u2212)-epigallocatechin-3-gallate in rat aorta","volume":"147","author":"Alvarez","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0185","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.bjp.0701011","article-title":"Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat","volume":"120","author":"Andriambeloson","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0190","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0006-291X(90)91544-3","article-title":"Chelerythrine is a potent and specific inhibitor of protein kinase C","volume":"172","author":"Herbert","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0195","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0022-3565(25)22524-1","article-title":"Effect of protein kinase C on cyclic 3\u2032,5\u2032-adenosine monophosphate-dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts","volume":"270","author":"Lee","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0006-2952(90)90650-A","article-title":"Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells","volume":"39","author":"Lugnier","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(97)00149-0","article-title":"Chelerythrine, a protein kinase C inhibitor, interacts with cyclic nucleotide phosphodiesterases","volume":"324","author":"Eckly-Michel","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1476-5381.1992.tb14345.x","article-title":"Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha1-adrenoceptor and benzothiazepine binding site at the calcium channel","volume":"106","author":"Ivorra","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-2999(93)90445-N","article-title":"Selective action of two aporphines at \u03b1l-adrenoceptors and potential-operated Ca2+ channels","volume":"231","author":"Ivorra","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0220","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/np50047a015","article-title":"Annonaceae alkaloids. Minor alkaloids from the bark of Pseudoxandra sclerocarpa","volume":"49","author":"Cortes","year":"1986","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0225","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1476-5381.1993.tb13598.x","article-title":"Investigations of the dual contractile\/relaxant properties showed by antioquine in rat aorta","volume":"109","author":"Ivorra","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0230","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1476-5381.1994.tb17150.x","article-title":"Mechanism of the cardiovascular activity of laudanosine: comparison with papaverine and other benzylisoquinolines","volume":"113","author":"Chulia'","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0235","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1055\/s-2004-827181","article-title":"Vascular activity of (\u2212)-anonaine, (\u2212)-roemerine and (\u2212)-pukateine, three natural 6\u03b1(R)-1,2-methylenedioxyaporphines with different affinities for alpha1-adrenoceptor subtypes","volume":"70","author":"Valiente","year":"2004","journal-title":"Planta Med."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0240","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0022-3565(25)09531-X","article-title":"The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity","volume":"273","author":"Barnette","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.bjp.0701124","article-title":"In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors","volume":"121","author":"Gantner","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1054-3589(08)60128-3","article-title":"The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions","volume":"44","author":"Houslay","year":"1998","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0255","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","article-title":"Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages","volume":"175","author":"Jin","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0260","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1124\/jpet.300.2.559","article-title":"Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-alpha) biosynthesis in alveolar epithelial cells","volume":"300","author":"Haddad","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0265","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2010.01.021","article-title":"The flavonoid dioclein reduces the production of pro-inflammatory mediators in vitro by inhibiting PDE4 activity and scavenging reactive oxygen species","volume":"633","author":"Guabiraba","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0270","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0031-9422(00)94358-9","article-title":"The production of resveratrol and viniferins, by grapevines in response to ultraviolet irradiation","volume":"16","author":"Langcake","year":"1977","journal-title":"Phytochemistry"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0275","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1570163054866873","article-title":"Reverse pharmacognosy: application of selnergy, a new tool for lead discovery. The example of epsilon-viniferin","volume":"2","author":"Do","year":"2005","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0280","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1021\/jm021062y","article-title":"Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model","volume":"46","author":"Graffner-Nordberg","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0285","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejmech.2015.12.002","article-title":"Discovery and modelling studies of natural ingredients from Gaultheria yunnanensis (FRANCH.) against phosphodiesterase-4. Eur","volume":"114","author":"Cai","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0290","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0378-8741(00)00341-X","article-title":"Plants used against cancer \u2013 an extension of the work of Jonathan Hartwell","volume":"73","author":"Graham","year":"2000","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0295","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/np068054v","article-title":"Natural products as sources of new drugs over the last 25 years","volume":"70","author":"Newman","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0300","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/01635581.2012.630551","article-title":"Cancer cell signaling pathways targeted by spice-derived nutraceuticals","volume":"64","author":"Sung","year":"2012","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0305","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/nu8080495","article-title":"Spices for prevention and treatment of cancers","volume":"8","author":"Zheng","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0310","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10428190009057627","article-title":"The cAMP signaling pathway as a therapeutic target in lymphoid malignancies","volume":"37","author":"Lerner","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0315","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0090-1229(83)90124-1","article-title":"Alterations of peripheral blood lymphocyte cyclic AMP and cyclic GMP in untreated patients with hodgkin's disease","volume":"26","author":"Aleksijevic","year":"1983","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0320","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0192-0561(87)90119-6","article-title":"Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes","volume":"9","author":"Aleksijevic","year":"1987","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0325","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.V61.3.429.429","article-title":"Plasma and urine cyclic nucleotide levels in patients with acute and chronic leukemia","volume":"61","author":"Peracchi","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0330","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1160\/TH03-02-0084","article-title":"VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors","volume":"90","author":"Favot","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0335","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1160\/TH03-12-0768","article-title":"Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4","volume":"92","author":"Favot","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0340","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-2006-957412","article-title":"Inhibitory effect of delphinidin from Solanum melongena on human fibrosarcoma HT-1080 invasiveness in vitro","volume":"64","author":"Nagase","year":"1998","journal-title":"Planta Med."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0345","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0006-2952(02)01568-X","article-title":"Delphinidin inhibits endothelial cell proliferation and cell cycle progression through a transient activation of ERK-1\/\u22122","volume":"65","author":"Martin","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0350","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0008-6363(03)00433-4","article-title":"Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis","volume":"59","author":"Favot","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145291","article-title":"Delphinidin inhibits tumor growth by acting on VEGF signalling in endothelial cells","volume":"10","author":"Keravis","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0360","first-page":"363","article-title":"Anticancer potential of curcumin: preclinical and clinical studies","volume":"23","author":"Aggarwal","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0365","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2004.09.041","article-title":"Chemopreventive and therapeutic effects of curcumin","volume":"223","author":"Duvoix","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0370","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bcp.2008.07.031","article-title":"Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells","volume":"76","author":"Reuter","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0375","first-page":"185","article-title":"Possible anti-tumour promoting properties of traditional Thai food items and some of their active constituents","volume":"3","author":"Murakami","year":"1994","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0380","series-title":"Cyclic Nucleotide Phosphodiesterases in Health and Disease, CRC 2006, Boca Raton, Fl","first-page":"417","article-title":"Role of PDEs in vascular healty and disease: endothelial PDEs and angiogenesis","author":"Keravis","year":"2006"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0385","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1160\/TH14-05-0454","article-title":"Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition","volume":"113","author":"Abusnina","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0390","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.bjc.6601068","article-title":"ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells","volume":"89","author":"Mousli","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0395","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1356-9597.2004.00710.x","article-title":"Down-regulation of nuclear protein ICBP90 by p53\/p21Cip1\/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1\/S transition","volume":"9","author":"Arima","year":"2004","journal-title":"Genes Cells"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0400","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature07273","article-title":"Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1","volume":"455","author":"Avvakumov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0405","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/mnfr.201100307","article-title":"Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1","volume":"55","author":"Abusnina","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0410","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/phrs.1999.0585","article-title":"Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection","volume":"41","author":"Nagi","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0415","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biocel.2005.10.009","article-title":"Thymoquinone: a promising anti-cancer drug from natural sources","volume":"38","author":"Gali-Muhtasib","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0420","first-page":"107","article-title":"In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone","volume":"22","author":"Shoieb","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0425","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.bcp.2009.12.015","article-title":"Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1","volume":"79","author":"Alhosin","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0430","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cellsig.2010.08.015","article-title":"Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis","volume":"23","author":"Abusnina","year":"2011","journal-title":"Cell. Signal."},{"issue":"2006","key":"10.1016\/j.cellsig.2017.07.018_bb0435","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuropharm.2006.04.013","article-title":"Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis","volume":"51","author":"Siuciak","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0440","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.107.132910","article-title":"Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia","volume":"325","author":"Schmidt","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0445","series-title":"A Molecular Mechanism of Action of Theophylline: Induction of Histone Deacetylase Activity to Decrease Inflammatory Gene Expression P.N.A.S","first-page":"8921","volume":"99","author":"Ito","year":"2002"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090907","article-title":"Caffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genes","volume":"9","author":"Al-Ansari","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0455","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jnutbio.2016.03.013","article-title":"The citrus flavonone naringenin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-\u03baB activation","volume":"33","author":"Pinho-Ribeiroa","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0460","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2183\/pjab.87.66","article-title":"Green tea polyphenol sensing","volume":"87","author":"Tachibana","year":"2011","journal-title":"Proc. Jpn. Acad. Ser. B."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0465","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.biotechadv.2014.04.004","article-title":"Curcumin, a component of golden spice: from bedside to bench and back","volume":"32","author":"Prasad","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075356","article-title":"Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS","volume":"8","author":"Woo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0475","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-0035-1545845","article-title":"Bioactive natural products against prostate cancer: mechanism of action and autophagic\/apoptotic molecular pathways","volume":"81","author":"Gioti","year":"2015","journal-title":"Planta Med."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0480","first-page":"959","article-title":"Cancer chemopreventive activity of xanthohumol, a natural product derived from hop","volume":"1","author":"Gerhauser","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0485","article-title":"Ginsenosides as anticancer agents: in vitro and in vivo activities, structure\u2013activity relationships, and molecular mechanisms of action","volume":"3","author":"Nag","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0490","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.biopha.2016.11.072","article-title":"Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer","volume":"85","author":"Zheng","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0495","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.bcp.2010.06.036","article-title":"Cancer chemoprevention by dietary polyphenols: promising role for epigenetics","volume":"80","author":"Link","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0500","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1039\/c3np70031c","article-title":"Natural compounds with anti-ageing activity","volume":"30","author":"Argyropoulou","year":"2013","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0505","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0014-5793(77)80144-0","article-title":"Reciprocal interactions of ricin from Ricinus communis L. seeds with eukaryote ribosomes","volume":"76","author":"Lugnier","year":"1977","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0510","first-page":"127","article-title":"Ricin, the toxic protein of the castor-oil plant (Ricinus communis L). Structure and properties","volume":"28","author":"Lugnier","year":"1980","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0515","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0041-0101(80)90093-8","article-title":"Isolation and properties of two toxic tryptic peptides from ricin, the toxin of Ricinus communis L. (castor bean) seeds","volume":"18","author":"Creppy","year":"1980","journal-title":"Toxicon"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0520","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.1007\/s13277-015-4028-4","article-title":"Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances","volume":"36","author":"Tyagi","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellsig.2017.07.018_bb0525","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbagen.2016.03.024","article-title":"An in vitro evaluation of epigallocatechin gallate (eGCG) as a biocompatible inhibitor of ricin toxin","volume":"1860","author":"Dyer","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0530","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.drudis.2013.08.021","article-title":"Thymoquinone: fifty years of success in the battle against cancer models","volume":"19","author":"Schneider-Stock","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0535","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cyto.2009.11.005","article-title":"A review of the herbal phosphodiesterase inhibitors; future perspective of new drugs","volume":"49","author":"Rahimi","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.cellsig.2017.07.018_bb0540","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/cancers6010436","article-title":"The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment","volume":"6","author":"Fajardo","year":"2014","journal-title":"Cancer"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656817301948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656817301948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T17:56:39Z","timestamp":1750787799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656817301948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":108,"alternative-id":["S0898656817301948"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2017.07.018","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potentials of natural compounds acting on cyclic nucleotide phosphodiesterase families","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2017.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}